Zogenix to Release Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on February 28
Get Alerts ZGNX Hot Sheet
Join SI Premium – FREE
EMERYVILLE, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2018, after the market close, and will host a corporate update conference call and webcast on Thursday, February 28, 2019, at 4:30 PM Eastern Time.
Conference Call Details | |
Thursday, February 28 @ 4:30 PM Eastern Time/1:30 PM Pacific Time | |
Toll Free: | 877-407-9716 |
International: | 201-493-6779 |
Conference ID: | 13687457 |
Webcast: | http://public.viavid.com/index.php?id=133233 |
Replays available through March 14: | |
Domestic: | 844-512-2921 |
International: | 412-317-6671 |
Replay PIN: | 13687457 |
About ZogenixZogenix is a global pharmaceutical company committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases. For more information, visit www.zogenix.com.
CONTACTS:
ZogenixMelinda BakerSenior Director, Corporate Communications[email protected]
Investors Andrew McDonaldFounding Partner, LifeSci Advisors LLC+1 (646) 597-6987 | [email protected]
Source: Zogenix, Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Hess Corp. (HES) Tops Q1 EPS by 144c
- ConnectOne Bancorp (CNOB) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!